• MUFA diet increased fasting GIP concentration compared with CARB diet.
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• MUFA diet increased fasting GIP concentration compared with CARB diet.
• Insulin and gut peptide secretion was similar after SAFA diet vs MUFA diet.
• Compared to SAFA and MUFA meals, CARB meal reduced postprandial insulin:glucose ratio.
Background
Current dietary guidelines recommend the replacement of saturated fatty acids (SAFAs) with carbohydrates or monounsaturated fatty acids (MUFAs) based on evidence on lipid profile alone, the chronic effects of the mentioned replacements on insulin secretion and insulin sensitivity are however unclear.
Objective
To assess the chronic effects of the substitution of refined carbohydrate or MUFA for SAFA on insulin secretion and insulin sensitivity in centrally obese subjects.
Methods
Using a crossover design, randomized controlled trial in abdominally overweight men and women, we compared the effects of substitution of 7% energy as carbohydrate or MUFA for SAFA for a period of 6 weeks each. Fasting and postprandial blood samples in response to corresponding SAFA, carbohydrate, or MUFA-enriched meal-challenges were collected after 6 weeks on each diet treatment for the assessment of outcomes.
Results
As expected, postprandial nonesterified fatty acid suppression and elevation of Cpeptide, insulin and glucose secretion were the greatest with high-carbohydrate (CARB) meal. Interestingly, CARB meal attenuated postprandial insulin secretion corrected for glucose response; however, the insulin sensitivity and disposition index were not affected. SAFA and MUFA had similar effects on all markers except for fasting glucose-dependent insulinotropic peptide concentrations, which increased after MUFA but not SAFA when compared with CARB.
Conclusion
In conclusion, a 6-week lower-fat/higher-carbohydrate (increased by 7% refined carbohydrate) diet may have greater adverse effect on insulin secretion corrected for glucose compared with isocaloric higher-fat diets. In contrast, exchanging MUFA for SAFA at 7% energy had no appreciable adverse impact on insulin secretion.
Introduction
Central obesity, a component of the metabolic syndrome, is closely linked to insulin resistance and predisposed to the development of type 2 diabetes. The role of defective insulin secretion in the pathogenesis of type 2 diabetes, however, has received less attention. The high-fasting insulin concentration in type 2 diabetes patients in fact resembles insulin deficit rather than hyperinsulinemia under the condition of concurrently elevated glucose concentration. 1 Emerging evidence showed that decline of glucose tolerance may be elicited by the insulin secretory defect rather than by obesity itself. 2 WHO recommends a reduction in saturated fats to <10% energy (en) with the replacement of carbohydrate or monounsaturated fats, for CHD prevention. 3 A recent meta-analysis of observational studies does not support the association of aforementioned replacement of saturated fats with reduction in diabetes risk in healthy individuals. 4 Conflicting findings were reported by three large scale interventional studies5 , 6
and 7 (to be discussed in Discussion part).
Gastrointestinal peptides such as glucagon-like peptides (GLP-1), glucosedependent insulinotropic polypeptide (GIP), ghrelin, peptide YY (PYY), and cholecystokinin (CCK) are short-term signals for satiety feedback to the brain and hence play a role in regulating glucose homeostasis.8 and 9 For example, lipidinduced CCK release was found to inhibit hepatic glucose production, and high-fat overfeeding was found to impair the gut-brain-liver neuronal mechanism hence leading to hyperglycemia. Materials and methods
Participants
The study protocol was approved by the Medical Ethics Committee of University of Malaya Medical Centre (reference no. 871.5). Participants gave informed written consent and attended a screening clinic. Fifty-four men and women aged 20-60 years with waist circumference ≥80 cm (for women) and ≥90 cm (for men) were recruited. Exclusion criteria were BMI ≤ 18.5 kg/m 2 ; medical history of CVD, diabetes, dyslipidemia; diagnosed chronic illness; current use of antihypertensive or lipid-lowering medication; plasma total cholesterol >6.5 mmol/L, triacylglycerol >4.5 mmol/L; alcohol intake >28 units/week; and lactating, pregnancy, and smoking. The flow of subject recruitment is shown in the CONSORT diagram ( Fig. 1) . Subjects' baseline characteristics are shown in Table 1 . Table options Experimental design
This was a randomized, controlled, single-blind, crossover trial under free-living conditions. The study design is outlined in Figure 2 . The study intervention was carried out from early March through mid-July 2012 at the Malaysian Palm Oil Board, Malaysia. Subjects were assigned to 3 consecutive 6-week isocaloric diets (∼2000 kcal/day): SAFA (control; 55% carbohydrate, 32% fat: 12% saturated fat, 13% monounsaturated fat), carbohydrate-enriched (CARB; 62% carbohydrate, 25% fat:5% SAFA, 14% MUFA) or MUFA (55% carbohydrate, 32% fat:5% SAFA, 20% MUFA) in random order using an orthogonal randomization allocation (treatment sequences in SAFA-MUFA-CARB, MUFA-CARB-SAFA, and CARB-SAFA-MUFA). Women were stratified according to menstrual cycle. Fasting blood samples were collected at baseline, week 5, and week 6 of each dietary intervention and mean values on treatment were estimated. After the fasting blood sample at week 6, an isocaloric (∼880 kcal) test challenge meal of echoing macronutrient composition to the background diet was consumed within 15 minutes, and postprandial blood samples were collected. The primary outcome was a postprandial change from fasting value in C-peptide, and secondary outcomes were postprandial changes in glucose, NEFA, and gut peptides (GLP-1, GIP, ghrelin, PYY, and CCK). All other outcomes were exploratory. Compliance to the intervention was monitored by changes in blood lipids. Power calculations were based on a mean differential postprandial increment of C-peptide from baseline concentration of 302.46 IU with a significance level (alpha) of 0.05 (two-tailed), which gave 90% power to detect a difference in 44 subjects. This estimate is based on a mean plasma C-peptide increment of 1049 IU with a within subject SD of 490 for a healthy, adult population from our unpublished data. Formulation of the test diets Experimental diets were designed based on the mean calorie requirement of participants based on a 3-day dietary record before study commencement analyzed with Nutritionist Pro software (AXXYA Systems LLC., Stafford, TX). The test diets provided ∼2000 kcal/d with 14% en protein standardized across diets and contained similar proportions of polyunsaturated fatty acids ( Table 2 ). The basal diets supplied 22-g fat to which 49-g oil was added on the SAFA (palm olein) and MUFA (high oleic sunflower oil blend) diets and 34-g (high-oleic sunflower oil blend) on the CARB with an additional 28 g of simple sugar supplied as sweetened drinks. All 3 main meals and snacks during the weekdays were prepared by a trained caterer according to trial specifications. Test oils were provided for weekend home meal preparation. Three 5-day rotational menus were designed with macronutrient composition calculated using Nutritionist Pro software (AXXYA Systems LLC., Stafford, TX, USA). Test cooking, laboratory macronutrient analyses, and fatty acid composition analyses were conducted to ascertain the desired nutrient profile as reported in our previous study. 17 The typical test diets consisted of a serving of white rice, fish or chicken, fruit, and drink; and two servings of vegetable (example of a menu day refer to Supplemental Table 1 ). Sweetened barley, honey, or rose syrup drinks (mean glycemic index (GI), 35.5 and glycemic load, 21.6) 18 were provided alternately to achieve desired medium GI content in the CARB diet, which is representative of the typical South East Asian menu. Additional energy requirements were adjusted on an individual basis using snacks (pancake and cupcake) prepared with macronutrient composition similar to the respective background dietary treatments. 12.0 ± 0.4 4.5 ± 0.5 5.0 ± 0.8 MUFA (% en)
13.1 ± 0.3 14.0 ± 0.5 20.5 ± 1.0 PUFA (% en) 6.4 ± 0.6 5.8 ± 0.5 6.0 ± 0.5 Dietary fiber (g) * 11.3 ± 3.7 12.8 ± 3.7 11.3 ± 3.7 en, energy; SAFA, saturated fatty acids; CARB, carbohydrate; MUFA, monounsaturated fatty acids; PUFA, polyunsaturated fatty acids.
Mean values ± SD. Duplicates of the meals were collected for total fat (Soxhlet method) and protein content (Kjeldah method). * Calculated using Nutritionist Pro software (AXXYA Systems LLC. TX, USA). Table options Isocaloric mixed meal challenge Subjects were provided low-fat chicken-flavored instant cup porridge (Natures Own, Malaysia) as dinner the night before the isocaloric mixed meal challenge. A cannula was inserted into the antecubital vein of the subject's forearm, 2 baseline fasting blood samples were then collected at −5 and 0 minutes. Subjects were provided isocaloric mixed meals (a muffin with a glass of 250-mL strawberryflavored milkshake) providing ∼880 kcal with 16-g protein. The high-fat (for both SAFA and MUFA) challenge meals provided 51-g fat and 88-g carbohydrate; whereas the low-fat/high-carbohydrate meal (CARB) provided 21-g fat and 158-g carbohydrate. The additional carbohydrate in CARB muffin and milkshake was supplied by Valens Carborie glucose polymers module (Pharm-D, USA). Blood samples were collected at baseline (in duplicate), 15, 30 minutes, and hourly till the 6 hour time-point.
Subject compliance
To ensure strict dietary compliance, subjects who failed to collect >10% meals during each 6-week intervention were considered drop-outs. Subjects were weighed bi-weekly, and percentage body fat was assessed using a body composition analyzer (TANITA). Dietary advice was given to those who experienced >2-kg weight fluctuation. The acceptability and palatability of the three diets were evaluated using visual analog scales. Plasma and erythrocyte membrane lipid extract were collected at the end of each dietary intervention phase for the analysis of fatty acid composition. Fasting serum triacylglycerol and total, LDL, and HDL cholesterol concentrations were also measured after the completion of each dietary phase.
Biochemical analysis and lipid assay
All blood samples were collected by standard venipuncture procedures and drawn into blood collection tubes (VACUETTE, Greiner Bio-One, Germany) containing the corresponding additives. EDTA vacutainers for high-sensitivity GLP-1 and total GIP were added with dipeptidyl peptidase-IV inhibitor (Millipore Corporation, UK). EDTA vacutainers for total ghrelin, total PYY, and CCK were added with 4-(2-aminoethyl) benzenesulfonyl fluoride hydrochloride (R&D Systems, USA). Packed erythrocyte where plasma was removed after centrifugation was stored at 4°C for 3 to 5 days before treatment according to method specified in Rose and Ocklander. 19 All samples were kept frozen at −80°C until analysis.
Fatty acid composition of test oils, fat extracted from diets, plasma, and erythrocyte membrane lipid extract was analyzed by gas chromatography on a BPX 70 column (30 m × 0.25 mm; SGE Sarl, Courtaboeuf, France). Serum C-peptide, insulin, Fructosamine, lipid, and plasma glucose samples were analyzed by an accredited pathology laboratory (Pathlab & Clinical Laboratory (M) Sdn Bhd). The analyses were performed with conventional methods using Siemens Advia 2400 chemistry analyzer (Siemens Healthcare Diagnostics Inc.).
Calculations
HOMA2-IR and insulin sensitivity (HOMA2-%S) were calculated based on fasting insulin and glucose concentrations, whereas β-cell function (HOMA2-%B) was derived from fasting C-peptide and glucose concentrations by using the HOMA calculator, version 2.2.2 (http://www.dtu.ox.ac.uk/homacalculator/, accessed June 2014). RQUICKI was calculated as 1/(log fasting insulin (μU/mL) + log fasting glucose (mg/dL) + log fasting NEFA (mmol/L)). 20 Incremental AUCs (iAUCs) were calculated by the conventional trapezoid rule after the subtraction of baseline reading. Insulin response corrected for glucose was defined as iAUCinsulin/glucose (0-120 min). Disposition index (DI) was calculated by multiplying insulin response corrected for glucose with HOMA2-%S.
Statistical analysis SPSS software (version 18; SPSS Inc, Chicago, IL) was used for statistical analysis. Standard distributional checks were made, logarithmic and square root transformations were performed to normalize data, and the transformed data were presented as geometric mean or else as mean. Data were analyzed using one-way repeated measure ANOVA, with time and meal as within-subject factors and gender as a between-subject factor. Comparisons between treatments were made using Bonferroni post hoc test. The iAUCs were calculated using GraphPad Prism software (version 5.02; Graph Pad software, Inc., La Jolla, CA). Results were reported as mean/geometric mean ± SEM for fasting measurements after diet intervention or geometric mean (95% CI) for measurements during postprandial challenge.
Results
Of 54 abdominally overweight participants randomized into the three dietary interventions, 7 subjects withdrew, and 1 subject was unwilling to participate in the mixed meal postprandial challenge. Data were available for the postprandial measures on 46 participants and 47 for fasting measures. Their details are shown in Table 1 . Waist circumference was >80 cm in women and 90 cm for men, the participants showed elevated fasting insulin concentration, which was approximately twice the value reported in nonobese Malaysian subjects. 17 Mean age, BMI, waist circumference, fasting plasma glucose, and HOMA2-%S were 32.8 ± 8.7 years, 28.7 ± 4.1 kg/m 2 , 94.8 ± 10.2 cm, 5.8 ± 0.8 mmol/L, and 70.8 ± 34.8, respectively. Of the 47 participants who completed the study, 59.6% had prior undiagnosed impaired fasting glucose levels (5.6-6.9 mmol/L), and 6.4% had previously undiagnosed diabetes (≥7.0 mmol/L) based on ADA criteria 21 ;
40.4% had blood pressure >130/85 mm Hg; 38.3% had LDL cholesterol >3.4 mmol/L.
Compliance
Subjects' body weight (74.2 ± 14.6 kg) remained constant throughout study intervention. Compliance to the SAFA, CARB, and MUFA diets was good with achieved meal attendance of 97.1 ± 4.4%, 98.0 ± 3.2%, and 97.1 ± 5.1%, respectively. Meal acceptability ratings of 7.0 ± 1.2, 7.1 ± 1.3, 6.9 ± 1.4 and palatability ratings of 7.2 ± 1.3, 7.3 ± 1.3, 7.1 ± 1.4 indicated that the three diets were equally well-accepted. Changes observed in plasma fatty acid composition between diets confirmed good dietary compliance. SAFA diet (26.8 ± 2.3%) had higher plasma palmitic acid levels compared with CARB (26.3 ± 1.8%) and MUFA diets (26.0 ± 2.0%), respectively (P < .05); whereas SAFA diet (22.8 ± 3.0%) exhibited lower oleic acid content compared with both CARB (24.7 ± 2.7%) and MUFA (25.0 ± 3.3%) diets (P < .05). Changes in lipid profile ( Table 3) were in agreement with those previously reported 22 where both total and LDL cholesterol concentrations were mildly increased (3.8%-5.5%) after SAFA diet compared with MUFA diet (4.89 ± 0.73 vs 4.71 ± 0.82 mmol/L; 3.05 ± 0.56 vs 2.89 ± 0.64 mmol/L; P < .05). HDL cholesterol concentrations were 4.2% higher after SAFA diet compared with CARB diet (1.23 ± 0.22 vs 1.18 ± 0.21 mmol/L; P < .05). No significant differences were observed between diets in terms of effect on total:HDL cholesterol ratio, apo-B100, apo-A1, lipoprotein (a), and triacylglycerol. Values are means ± SEM (*) or else geometric means ± SEM for normalized data. n = 47 (women n = 35; men n = 12), measured at fasting state. † n = 46 (women n = 34; men n = 12), measured during postprandial challenge. Table options Postprandial C-peptide, insulin, glucose, and NEFA responses
The primary outcome, postprandial changes in C-peptide in response to the isocaloric challenge meal after 6 weeks of dietary intervention were found to express a significant meal × time × gender interaction (P = .007) after all meals ( Supplemental Fig. 1 ). Women showed a delayed postprandial C-peptide increase at 2 hours but sustained a higher level after 2 hours compared with men. Plasma C-peptide was found to peak at 2.15 (1.92-2.37) nmol/L (at 60 minutes), 3.61 (3.14-4.09) nmol/L (at 120 minutes), 2.28 (1.95-2.61) nmol/L (at 120 minutes) for the SAFA, CARB, and MUFA meals, respectively. With all 3 meals, C-peptide levels returned to baseline at 6 hours (P < .001; Fig. 3 ). The iAUCC-peptide (0-120 min)were 77% and 72% higher after CARB meal compared with SAFA and MUFA meals (P < .001). As expected, insulin and glucose showed a significant meal × time interaction (P = .000), with CARB meal displaying a higher increase compared with SAFA and MUFA meals. Glucose concentrations were found to peak at 30 minutes, and the peak glucose after CARB meal was 25% higher compared with both high-fat meals (9.29 [8.84-9 .73] (CARB) vs 7.59 [7.20-7 .98] (SAFA), 7.44 [7.09-7 .79] (MUFA) mmol/L). The iAUC0-120 minof insulin, glucose, and NEFA after CARB meal were 98%, 110%, and 28% higher compared with SAFA meal and 86%, 107%, and 36% higher compared with MUFA meal (P < .001 for all comparisons). Insulin response corrected for glucose (P = .048) but not DI (P = .095) tended to be lower after the CARB meal compared with the two high-fat meals (Table 3 ). There was a significant meal × time × gender interaction (P = .030) between meals for NEFA ( Supplemental Fig. 1 ). Postprandial gastrointestinal peptide release
The changes in gastrointestinal peptide concentrations are depicted in Figure 3 . There were significant changes observed for GLP-1, GIP, and ghrelin after all meals (meal × time interaction: P = .000). GLP-1 concentrations were higher at 15 and 30 minutes but lower at 6 hours (P < .05) after CARB meal compared with both high-fat meals. GIP and ghrelin were found to express a significant gender × time interactions (P < .05; Supplemental Fig. 1 ). The pattern of increase of GLP-1 at 15 and 30 minutes was mimicked by GIP, followed by a sharp decrease following CARB at 4 and 6 hours compared with MUFA but not SAFA meal (P < .05). Lower ghrelin level was detected at 4 hours after CARB meal compared with high-fat meals (P < .05). PYY showed a significant meal × time interaction (P = .000). No significant differences were detected between all meals in CCK. The iAUC0-120 min for all gastrointestinal peptides did not differ between meals.
Fasting insulin secretion, insulin sensitivity, and gastrointestinal peptides No significant differences were observed between the impact of the 3 diets on fasting C-peptide, insulin, NEFA, glucose, fructose, RQUICKI, HOMA2-%S, HOMA2-%B, and HOMA2-IR after each 6-week dietary intervention (Table 3) . Fasting GIP concentrations were 18.0% lower after CARB diet compared with MUFA diet (P < .05). No appreciable differences between the 3 dietary interventions were observed in fasting GLP-1, ghrelin, PYY, and CCK.
Discussion
The present study was designed to investigate both fasting and postprandial effects of the replacement of SAFA with carbohydrate or MUFA on insulin secretion and sensitivity, glucose homeostasis, and gastrointestinal peptide release in subjects with central obesity after a 6-week isocaloric dietary intervention. As expected, the primary outcome of the study as assessed by the postprandial changes in the absolute C-peptide levels were higher after a highcarbohydrate/low-fat mixed meal following a 6-week background diet enriched with 7% en carbohydrate in replacement of SAFA and MUFA. Despite the exaggerated increase in plasma insulin after CARB meal, peak plasma glucose was found to be 19% higher after CARB meal than the normal glycemic response after the meal for healthy subjects (<7.8 mmol/L) as defined by the International Diabetes Federation. 20 Furthermore, our study noted a delayed insulin peak at 2 hours in the South East Asian subjects compared with data obtained from the Caucasians where insulin peaked at 30 minutes, 23 which indicated impaired insulin sensitivity in this population. 24 We can perhaps infer therefore that the habitual diet consumed by South East Asian populations, which consists of around 60% en carbohydrate with the majority comprised refined carbohydrate, predisposes the population to higher incidence of type 2 diabetes mellitus. 25 The present study also found that the postprandial insulin response corrected for glucose after CARB meal tended to be lower compared with both high-fat meals. The amount of carbohydrate administered (158 g) represents the amount of carbohydrate in a typical set meal in South East Asia, that is, pasta or fried rice with a sweetened drink. Hence, our findings imply that if an increase as little as 7% en on moderate GI-refined carbohydrate (within a short period of 6 weeks) in centrally obese subjects can attenuate insulin response corrected for glucose, repetitive exposure to insulin hypersecretion may lead to the early exhaustion and apoptosis of β cells and hence the increased risk of developing type 2 diabetes.26 and 27 On the other hand, our present study found that the NEFA suppression following a high-carbohydrate meal is greater compared with both high-fat meals as greater insulin secretion in response to carbohydrate inhibits lipolysis. In line with our findings, other studies have demonstrated that the higher carbohydrate:fat ratio alleviates postprandial NEFA concentrations,28 and 29 which could be explained by the NEFA-suppressing effect of insulin overriding NEFA spillover as a consequence of high-fat intake. 30 The suppression of NEFA by a high-carbohydrate meal promotes the storage of body fat. Our study also demonstrated that the quality and quantity of fats at 7% en exchange did not alter fasting insulin secretion and sensitivity as measured by HOMA2-%S or glucose homeostasis after a 6-week isocaloric dietary intervention in abdominal overweight individuals. In accordance to the findings of our previous study in healthy subjects 17 and 2 large scale studies in insulin resistant 7 and metabolic syndrome 6 subjects, our results showed that diet enrichment with SAFA is comparable with carbohydrate or MUFA with regard to its effect on insulin sensitivity. Both the RISCK 7 and LIPGENE 6 studies found that the substitution of SAFA with carbohydrate and MUFA did not result in significant differences in insulin sensitivity and acute insulin response to glucose. Another large scale study, the KANWU 5 study however reported borderline significant difference in treatment effect between SAFA and MUFA (P = .053) where SAFA impaired insulin sensitivity compared to baseline, whereas no appreciable difference was detected in insulin secretion and first-phase insulin response (acute insulin response to glucose was not measured). The wide variation of total fat intake (29-45% en) in the free-living subjects and the weaker baseline insulin sensitivity in the SAFA group may have confounded the finding of the parallel-designed KANWU study. Our study avoided such limitation by setting each subject as his own control using the crossover design and by providing centrally prepared meals. Furthermore, we found DI was similar after all diets, whereas none of the four mentioned study made the measurement. Our investigation on the concomitant changes of gastrointesinal peptides is not prominent in most other studies. We observed a decrease in fasting GIP level after CARB diet compared with MUFA diet. This observation is novel. There is positive in vivo evidence that reduced fasting GIP concentrations are associated with improved insulin sensitivity 31 and 32; our findings however did not concur with this observation. The contradiction may suggest that the reduced fasting GIP concentrations as observed after a 6-week CARB diet may not be related to the intrapancreatic actions. This may be explained by the observations of two shortterm feeding intervention studies, which reported that high-fat overfeeding increased fasting GIP concentrations 33 and 34 possibly due to fat deposition. It was reported that GIP binds to its receptor on adipose tissue and increases the adipose tissue volume. 35 The reduced fasting GIP levels as observed in CARB diet group may indicate lesser fat deposition, which needs further confirmation. Our study showed no appreciable differences between meals in the postprandial gastrointestinal peptide responses as indicated by iAUC0-120 min. The spikes of GLP-1 and GIP at the early phase occurred in response to the noticeably elevated glucose level after CARB meal, which stimulated insulin secretion and inhibit glucagon secretion. High-fat meal has been found to create greater rise in GLP-1 and PYY than high-carbohydrate meal over the 3-hour measurement in healthy adults,41 and 42 we however did not observe such difference. The impaired GLP-1 and PYY responses after high-fat load may be due to insulin resistance and impaired glucose homeostasis in our obese subjects. 43 Studies have reported that in healthy subjects, carbohydrate results in greater postprandial ghrelin suppression in the first 3 hours than fat. 44 However, blunted ghrelin suppression by carbohydrate was demonstrated in our abdominally overweight subjects. This is pursuant to the finding that postprandial ghrelin response is independent of macronutrient composition in obese subjects. we found that alterations in fat quantity had similar impact on postprandial PYY and CCK in our obese subjects. The lipid-sensing action of PYY and CCK appeared to be less sensitive in overweight or obese subjects. All together, the differential effects of fat quality and fat quantity on gastrointestinal peptides were not seen in our subjects with abdominal obesity with majority of them having impaired fasting glucose and insulin resistance. Because the release of gastrointestinal peptides is controlled by neuronal and humoral interaction between the brain and gut, the impaired gastrointestinal peptide secretion may reflect brain-gut miscommunication in this group of population. 49 The disregulation could cause over-feeding and dis-inhibition of liver glucose production and thus facilitate the development of obesity and metabolic disturbances.
49
The present study has limitations. As the study subjects were abdominally overweight with the majority having insulin resistance and undiagnosed dysglycemia before enrollment, the findings from this study may not be generalized to all other populations. The subjects were of South East Asian origin; hence, they represented a high-risk population, which are susceptible to the development of diabetes mellitus. 50 There are several strengths of the study. First, this study design incorporated a controlled dietary intervention under free-living conditions that reflects South East Asian diets. Second, we achieved good compliance with the dietary intervention that resulted in expected changes in lipid profile and plasma fatty acid composition, as well as a constant subject body weight across all 3 diets for the entire study duration. The changes in insulin secretion and sensitivity were measured at physiological levels, which reflected real life scenarios. Lastly, unlike many studies we also calculated insulin response corrected for glucose and DI, which are more valid measures of insulin secretion.
In conclusion, a 7% en exchange of carbohydrate with SAFA impaired insulin secretion corrected for glucose but had no effect on insulin sensitivity, glucose homeostasis, and gastrointestinal peptide concentrations in abdominally overweight individuals after a 6-week isocaloric dietary intervention. As expected, high-carbohydrate meal increased insulin and glucose secretions, which may be detrimental to β-cell function in the long run as evidenced by the reduced insulin secretion corrected for glucose ratio. The type of fat, that is, SAFA and MUFA, however did not exert differential impact on glucose homeostasis, insulin sensitivity, insulin secretion, and gastrointestinal peptide release under fasting and postprandial conditions.
Uncited reference 51 .
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